It has been shown that amyloid plaques can disrupt PI3K signalling by stimulating both NF-κB and mTOR, enhancing glial activation and preventing the switch to an anti-inflammatory state, highlighting PI3K’s association with AD progression [79]. Here, NFKB1 is linked to Alzheimer disease.